4//SEC Filing
Daly Jason B. 4
Accession 0001723128-25-000049
CIK 0001723128other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:39 PM ET
Size
5.0 KB
Accession
0001723128-25-000049
Insider Transaction Report
Form 4
Daly Jason B.
EVP, Chief Legal Officer
Transactions
- Sale
Class A Common Stock
2025-08-12$9.05/sh−22,000$199,100→ 10,606 total
Footnotes (1)
- [F1]The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.01 to $9.13 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001906486
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 4:39 PM ET
- Size
- 5.0 KB